中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Joohang KIM)

1.A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement.

Min Hwan KIM ; Yehyun PARK ; Hye Jung PARK ; Ah Young JI ; Changho SONG ; Moo Nyun JIN ; Young Ju KIM ; Sun Wook KIM ; Jung Hee LEE ; In Soo KIM ; Hye Ryun KIM ; Joohang KIM ; Byoung Chul CHO

The Ewha Medical Journal 2014;37(1):46-51

2.Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer.

Yong Joon PARK ; Eun Hee KOH ; Joohang KIM ; Jae Kyung ROH ; Joon CHANG ; Chul Min AHN ; Hee Young SOHN ; Sung Kyu KIM ; Won Young LEE ; Kiho KIM ; Chang Ok SUH ; Gwi Eon KIM ; John J K LOH ; Byung Soo KIM

Yonsei Medical Journal 1989;30(1):30-37

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO